1-10-2008: Cellerix obtains a 10M€ debt facility with ETV Capital
The biopharmaceutical company will be able to finalize clinical development of Ontaril®, its treatment for Perianal Fistulas for Crohn and non-Crohn patients.
20-05-2008: Guillermo Sellers named VP Medical and Regulatory of Cellerix
Cellerix has appointed Guillermo Sellers as the new Medical and Regulatory Vice President of its management team
22-04-2008: Miguel Fenoy, the New Director of Clinical Operations at Cellerix
Cellerix has appointed Miguel Fenoy to its team as Director of Clinical Operations.
15-04-2008: Cellerix registers the name Ontaril® for its medicine Cx401
Cellerix has registered the name Ontaril® for its medicine Cx401.
24-03-2008: Miguel Ángel Galve, new Legal Manager of Cellerix
Cellerix has incorporated Miguel Ángel Galve to their team as Legal Manager.